An anti-HER2 ADC binds ERBB2 on tumor cells, is internalized, and releases a camptothecin/topoisomerase I–inhibitor payload (rezetecan) that causes DNA strand breaks leading to apoptosis; the antibody Fc can also trigger ADCC.